Stay updated on Orally Administered AG-120 in Hematologic Malignancies Clinical Trial
Sign up to get notified when there's something new on the Orally Administered AG-120 in Hematologic Malignancies Clinical Trial page.

Latest updates to the Orally Administered AG-120 in Hematologic Malignancies Clinical Trial page
- CheckyesterdayChange DetectedA new revision entry v3.6.6 was added to the history and the previous revision v3.6.5 was removed. This reflects an update to the record’s metadata rather than changes to the study data or outcomes.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe history now includes a new revision entry v3.6.5, and the previous v3.6.4 entry was removed. This reflects a small metadata update to the page's revision history.SummaryDifference0.1%

- Check36 days agoChange DetectedA new Revision: v3.6.4 is added to the history and the previous Revision: v3.6.3 is removed, indicating a recent site release update.SummaryDifference0.1%

- Check58 days agoChange DetectedThe page history shows the latest revision updated to v3.6.3, replacing the previous v3.6.2. This reflects a minor update to the page's version rather than changes to study details.SummaryDifference0.1%

- Check65 days agoChange DetectedA new site revision entry v3.6.2 was added to the history, and the previous entry v3.6.0 was removed. This represents a minor background release update to the site rather than changes to the study data or public study information.SummaryDifference0.1%

- Check72 days agoChange DetectedA new 'Study Status' entry was added to the record history with associated date markers (2026-06-15 and 2026-06-11) and the value 50, while the existing entry from 2025-06-08 was deleted, updating the history timeline to reflect the latest status information.SummaryDifference0.2%

Stay in the know with updates to Orally Administered AG-120 in Hematologic Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Orally Administered AG-120 in Hematologic Malignancies Clinical Trial page.